1 0

    FDA Drug Approval, A061212, BACITRACIN

    FDA Drug Approval, A061212, BACITRACIN

    $149.00 USD
    $149.00 USD
    Sale Sold out

    Contents: Summary Basis of Approval

    ANDA: 061212
    Company: PADAGIS US
    Drug Name: BACITRACIN
    Active Ingredients: BACITRACIN
    Strength: 500 UNITS/GM
    Dosage Form/Route: OINTMENT;OPHTHALMIC
    Action Date: 11/09/1971
    Marketing Status: Prescription
    Submission Classification: ORIG-1 TE Code: None

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details